Phio Pharmaceuticals Corp... (PHIO)
NASDAQ: PHIO
· Real-Time Price · USD
2.21
0.02 (0.91%)
At close: Aug 15, 2025, 3:59 PM
2.12
-4.07%
After-hours: Aug 15, 2025, 07:34 PM EDT
Phio Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.76M | -7.15M | -7.42M | -8.68M | -9.38M | -10.83M | -11.66M | -12.46M | -12.44M | -11.48M | -12.2M | -12.37M | -12.52M | -13.29M | -12.3M | -10.87M | -9.85M |
Depreciation & Amortization | 1K | 35K | 36K | 125K | 171K | 184K | 278K | 246K | 218K | 193K | 76K | 80K | 79K | 75K | 72K | 71K | 72K |
Stock-Based Compensation | 158K | 147K | 108K | 145K | 224K | 303K | 336K | 350K | 339K | 414K | 510K | 550K | 599K | 480K | 368K | 262K | 160K |
Other Working Capital | 915K | 1.33M | 42K | -476K | -616K | -1.15M | -311K | -17K | -764K | -1.75M | -623K | -418K | -49K | 1.44M | 386K | -331K | -84K |
Other Non-Cash Items | -419K | 21K | -233K | 843K | 846K | 488K | 660K | 40K | 52K | n/a | 121K | 119K | 118K | 117K | 115K | 114K | 113K |
Deferred Income Tax | n/a | n/a | 389K | -262K | -280K | -362K | -751K | -100K | -82K | n/a | n/a | -233K | -233K | -233K | -233K | n/a | n/a |
Change in Working Capital | 833K | 907K | 38K | -797K | -1.2M | -536K | 55K | 212K | 545K | -1.26M | -402K | 382K | -335K | 990K | -34K | -464K | -154K |
Operating Cash Flow | -5.78M | -6.52M | -7.52M | -9.06M | -10.05M | -10.75M | -11.08M | -11.71M | -11.37M | -12.13M | -11.89M | -11.47M | -12.29M | -11.86M | -12.01M | -10.88M | -9.66M |
Capital Expenditures | -3K | -1K | n/a | n/a | -5K | -5K | -119K | -126K | -131K | -235K | -121K | -144K | -149K | -51K | -52K | -30K | -15K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 9K | 9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 6K | 8K | n/a | n/a | -5K | -5K | -119K | -126K | -131K | -235K | -121K | -144K | -149K | -51K | -52K | -30K | -15K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9K | 213K |
Common Stock Repurchased | n/a | -4K | -4K | -4K | -4K | -13K | -13K | -16K | -16K | -28K | -29K | -26K | -26K | -1K | 1K | -7K | -7K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.68M | -5K | -5K | -5K | -5K | -26K | -23K | -26K | -26K | -26K | -29K | 207K | 207K | 21.72M | 21.76M | 21.52M | 28.91M |
Financial Cash Flow | 13.17M | 4M | 5.04M | 2.4M | 7.45M | 7.41M | 5.01M | 5.01M | -39K | -26K | -29K | 207K | 207K | 21.72M | 21.7M | 21.45M | 29.06M |
Net Cash Flow | 6.8M | -3.11M | -3.07M | -6.66M | -2.61M | -3.34M | -6.08M | -6.71M | -11.42M | -12.28M | -12.04M | -11.4M | -12.24M | 9.81M | 9.66M | 10.56M | 19.41M |
Free Cash Flow | -5.79M | -6.52M | -7.52M | -9.06M | -10.06M | -10.75M | -11.2M | -11.84M | -11.5M | -12.36M | -12.02M | -11.61M | -12.44M | -11.91M | -12.06M | -10.91M | -9.67M |